Sheriff leaves town as Angel blesses Stewart White as acting CEO
This article was originally published in Scrip
Executive Summary
Angel Biotechnology Holdings, a full service contract biomanufacturing partner to biotechnology and pharmaceutical companies, has appointed Dr Stewart White acting CEO following the resignation of Gordon Sherriff, Angel's COO. Dr White was originally recruited to Angel as commercial director in December 2011 with the view that he would progress to CEO in due course. Angel's board is confident Dr White's new role will be made permanent after an evaluation period. Dr White previously served in senior manufacturing and business development roles at Devro, an ex Johnson & Johnson company.
You may also be interested in...
Almirall launches Constella in six European markets
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira raises $35m in series B
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis ups public offering to $240m
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.